Oncology that carries responsibility. 

At CIS BIOPHARMA, we design the next generation of cancer therapies - targeted treatments that deliver maximum effect directly to tumor cells while minimizing harm to healthy tissue. 

Our focus

Antibody-Drug Conjugates (ADCs) - smarter chemotherapy 
Radiopharmaceuticals - targeted radiation from within 

Where standard therapies reach their limits, we create innovative solutions that matter

For partners, who seek to expand their oncology portfolio 
For investors, who look for sustainable value in breakthrough science 
For scientists, who want to advance research on unique targets like L1CAM 

What sets us apart? 
We combine cutting-edge science with a proven track record in oncology drug development and work closely with partners who share our mission to transform cancer care. 
 
Our strengths at a glance

• Unique tumor targets such as L1CAM 
• In-house Swiss labs for speed & quality 
• Proprietary chemistry & AI-driven protein engineering 

CIS BIOPHARMA

Org chart

Teams

Offices

CIS BIOPHARMA

Org chart

Teams

Offices

Related companies